Is the antidepressant venlafaxine effective for the treatment of functional dyspepsia?

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 6, Issue 2, 2009, Pages 74-75

  Van Oudenhove, Lukas ^a   Tack, Jan ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MIANSERIN; MIRTAZAPINE; PLACEBO; VENLAFAXINE;

ANXIETY; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; GASTROINTESTINAL SYMPTOM; HUMAN; MENTAL DISEASE; NAUSEA; NOTE; PRIORITY JOURNAL; QUALITY OF LIFE;

CYCLOHEXANOLS; DYSPEPSIA; HUMANS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 59949091936     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep1334     Document Type: Note

References (6)

1. van Kerkhoven LAS et al. (2008) Effect of the antidepressant venlafaxine in functional dyspepsia: A randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 6: 746-752
2. Van Oudenhove L et al. (2007) Relationship between anxiety and gastric sensorimotor function in functional dyspepsia. Psychosom Med 69: 455-463
3. Stahl SM (2008) Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge: Cambridge University Press
4. Chial HJ et al. (2003) Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. Am J Physiol Gastrointest Liver Physiol 284: G130-G137
5. Kindt S and Tack J (2006) Impaired gastric accommodation and its role in dyspepsia. Gut 55: 1685-1691
6. Tack J et al. (2006) A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut 55: 1095-1103